Cargando…
Beta-adrenergic receptors are expressed across diverse cancers
Based largely on retrospective analyses and a handful of prospective case reports, pharmacological inhibition of the beta adrenergic receptors using beta blockers has shown clinical anti-cancer efficacy in reproductive cancers, as well as angiosarcoma and multiple myeloma. Because of the potential p...
Autores principales: | Rains, Steven L., Amaya, Clarissa N., Bryan, Brad A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616202/ https://www.ncbi.nlm.nih.gov/pubmed/28966942 http://dx.doi.org/10.18632/oncoscience.357 |
Ejemplares similares
-
Targeting of Beta Adrenergic Receptors Results in Therapeutic Efficacy against Models of Hemangioendothelioma and Angiosarcoma
por: Stiles, Jessica M., et al.
Publicado: (2013) -
Beta Adrenergic Signaling: A Targetable Regulator of Angiosarcoma and Hemangiosarcoma
por: Dickerson, Erin B., et al.
Publicado: (2015) -
The beta adrenergic receptor antagonist propranolol alters mitogenic and apoptotic signaling in late stage breast cancer
por: Montoya, Alexa, et al.
Publicado: (2019) -
Anti-tumor activity of the beta-adrenergic receptor antagonist propranolol in neuroblastoma
por: Wolter, Jennifer K, et al.
Publicado: (2013) -
Non-selective beta blockers inhibit angiosarcoma cell viability and increase progression free- and overall-survival in patients diagnosed with metastatic angiosarcoma
por: Amaya, Clarissa N., et al.
Publicado: (2018)